Radiotherapy and chemotherapy in combined clinical trials: problems and promise.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001927:Brain Diseases / Q000209:etiology; D001932:Brain Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D001943:Breast Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D004359:Drug Therapy, Combination; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D006258:Head and Neck Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D008297:Male; D009369:Neoplasms / Q000188:drug therapy / Q000532:radiotherapy*; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000532:radiotherapy; D011878:Radiotherapy / Q000009:adverse effects; D012512:Sarcoma, Ewing / Q000188:drug therapy / Q000532:radiotherapy
D000970:Antineoplastic Agents